(Val(8))Glp-1-Glu-Pal: a Glp-1 agonist that improves hippocampal neurogenesis, glucose homeostasis, and beta-cell function in high-fat-fed mice
ns = no statistical difference
It is long enough to avoid the hassle of swapping vials every day or two
The SURPASS-1 to -5 clinical trials assessed the efficacy of once weekly tirzepatide (5, 10 and 15 mg) versus placebo or active comparators (semaglutide 1 mg, insulin degludec and insulin glargine) in T2D
The medication is administered via subcutaneous injection, typically on a weekly basis, though dosing frequency and amounts may be individualized based on patient response and tolerability
For instance, one drug could interfere with the metabolism of another, leading to increased drug levels and potential toxicity, or decreased levels, leading to reduced efficacy